Concepts (261)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Nicotinic | 6 | 2013 | 190 | 1.320 |
Why?
|
| Models, Chemical | 4 | 2006 | 186 | 1.100 |
Why?
|
| Stilbenes | 3 | 2017 | 86 | 0.810 |
Why?
|
| Membrane Potentials | 3 | 2006 | 424 | 0.760 |
Why?
|
| Adipose Tissue | 13 | 2018 | 769 | 0.710 |
Why?
|
| Models, Molecular | 5 | 2013 | 1732 | 0.690 |
Why?
|
| Cell Membrane | 3 | 2006 | 850 | 0.650 |
Why?
|
| Muscle, Skeletal | 8 | 2021 | 1270 | 0.560 |
Why?
|
| Ion Channel Gating | 2 | 2006 | 141 | 0.530 |
Why?
|
| Antioxidants | 2 | 2017 | 507 | 0.500 |
Why?
|
| Insulin Resistance | 6 | 2018 | 731 | 0.480 |
Why?
|
| Metabolic Syndrome | 2 | 2017 | 353 | 0.480 |
Why?
|
| Nicotinic Agonists | 2 | 2006 | 113 | 0.460 |
Why?
|
| Acetylcholine | 2 | 2013 | 96 | 0.390 |
Why?
|
| Torpedo | 3 | 2013 | 36 | 0.370 |
Why?
|
| Computer Simulation | 4 | 2006 | 1529 | 0.340 |
Why?
|
| Acetylcholinesterase | 1 | 2006 | 23 | 0.290 |
Why?
|
| Human Growth Hormone | 2 | 2018 | 82 | 0.280 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2019 | 268 | 0.250 |
Why?
|
| Binding Sites | 5 | 2013 | 2171 | 0.250 |
Why?
|
| Intra-Abdominal Fat | 2 | 2017 | 95 | 0.240 |
Why?
|
| Obesity | 6 | 2018 | 2884 | 0.230 |
Why?
|
| Diabetes Mellitus, Type 2 | 4 | 2016 | 1362 | 0.230 |
Why?
|
| Fluorescence Resonance Energy Transfer | 4 | 2008 | 91 | 0.230 |
Why?
|
| Static Electricity | 3 | 2006 | 58 | 0.210 |
Why?
|
| Thinness | 2 | 2016 | 82 | 0.210 |
Why?
|
| Triglycerides | 5 | 2017 | 603 | 0.210 |
Why?
|
| Insulin | 3 | 2017 | 1454 | 0.200 |
Why?
|
| Satellite Cells, Skeletal Muscle | 1 | 2021 | 33 | 0.200 |
Why?
|
| Liver | 4 | 2017 | 2961 | 0.200 |
Why?
|
| Glucose | 2 | 2018 | 1248 | 0.200 |
Why?
|
| Calmodulin | 3 | 2009 | 241 | 0.200 |
Why?
|
| Absorptiometry, Photon | 3 | 2017 | 239 | 0.190 |
Why?
|
| Progesterone | 1 | 2003 | 513 | 0.190 |
Why?
|
| Rats, Wistar | 8 | 2016 | 562 | 0.190 |
Why?
|
| Optic Atrophies, Hereditary | 1 | 2020 | 16 | 0.190 |
Why?
|
| COUP Transcription Factor I | 1 | 2020 | 81 | 0.180 |
Why?
|
| Body Composition | 3 | 2017 | 595 | 0.180 |
Why?
|
| Cholesterol | 4 | 2017 | 658 | 0.180 |
Why?
|
| Interleukin-6 | 3 | 2017 | 1038 | 0.180 |
Why?
|
| Glucocorticoids | 1 | 2003 | 629 | 0.180 |
Why?
|
| Software | 1 | 2006 | 1321 | 0.170 |
Why?
|
| Protein Binding | 7 | 2013 | 3438 | 0.170 |
Why?
|
| Maternal Exposure | 1 | 2019 | 160 | 0.160 |
Why?
|
| Models, Biological | 1 | 2006 | 3254 | 0.150 |
Why?
|
| Fructosamine | 1 | 2017 | 4 | 0.150 |
Why?
|
| Hypothermia | 1 | 2017 | 59 | 0.150 |
Why?
|
| Neuronal Plasticity | 1 | 2020 | 304 | 0.150 |
Why?
|
| Real-Time Polymerase Chain Reaction | 3 | 2017 | 1217 | 0.150 |
Why?
|
| Quadriceps Muscle | 1 | 2017 | 10 | 0.150 |
Why?
|
| Blood Glucose | 3 | 2017 | 1244 | 0.150 |
Why?
|
| TRPV Cation Channels | 1 | 2017 | 76 | 0.150 |
Why?
|
| Memory Disorders | 1 | 2020 | 295 | 0.150 |
Why?
|
| White Matter | 1 | 2019 | 195 | 0.150 |
Why?
|
| Hippocampus | 2 | 2020 | 915 | 0.150 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 1 | 2017 | 107 | 0.150 |
Why?
|
| Fasting | 1 | 2018 | 349 | 0.150 |
Why?
|
| Physical Conditioning, Animal | 1 | 2018 | 112 | 0.140 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2017 | 624 | 0.140 |
Why?
|
| Porosity | 2 | 2006 | 56 | 0.140 |
Why?
|
| Calcium Channels, L-Type | 2 | 2009 | 76 | 0.140 |
Why?
|
| Cranial Irradiation | 1 | 2018 | 315 | 0.140 |
Why?
|
| Spectrometry, Fluorescence | 3 | 2006 | 209 | 0.140 |
Why?
|
| Neurogenesis | 1 | 2018 | 238 | 0.130 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2018 | 630 | 0.130 |
Why?
|
| Cholesterol, HDL | 1 | 2017 | 341 | 0.130 |
Why?
|
| Leptin | 1 | 2017 | 295 | 0.130 |
Why?
|
| Blotting, Western | 3 | 2017 | 3536 | 0.130 |
Why?
|
| Glucose Intolerance | 1 | 2016 | 84 | 0.130 |
Why?
|
| Diet, Protein-Restricted | 1 | 2016 | 82 | 0.130 |
Why?
|
| Brain Ischemia | 1 | 2017 | 292 | 0.130 |
Why?
|
| Vitamins | 1 | 2015 | 157 | 0.130 |
Why?
|
| Glucose Transporter Type 4 | 2 | 2011 | 26 | 0.130 |
Why?
|
| Vitamin D Deficiency | 1 | 2015 | 115 | 0.120 |
Why?
|
| Recovery of Function | 1 | 2017 | 703 | 0.120 |
Why?
|
| C-Reactive Protein | 1 | 2017 | 527 | 0.120 |
Why?
|
| Double-Blind Method | 2 | 2017 | 2588 | 0.120 |
Why?
|
| Vitamin D | 1 | 2015 | 261 | 0.120 |
Why?
|
| Lipopolysaccharides | 1 | 2016 | 558 | 0.110 |
Why?
|
| Cholesterol, LDL | 1 | 2017 | 565 | 0.110 |
Why?
|
| Blood Pressure | 2 | 2017 | 1467 | 0.110 |
Why?
|
| Biopsy | 1 | 2021 | 3443 | 0.110 |
Why?
|
| Kinetics | 2 | 2006 | 2049 | 0.110 |
Why?
|
| Postprandial Period | 1 | 2013 | 85 | 0.110 |
Why?
|
| Animals | 20 | 2020 | 59536 | 0.110 |
Why?
|
| Eating | 2 | 2008 | 421 | 0.110 |
Why?
|
| Meals | 1 | 2013 | 66 | 0.110 |
Why?
|
| Stress, Psychological | 1 | 2019 | 1000 | 0.110 |
Why?
|
| Peptides | 3 | 2009 | 1479 | 0.110 |
Why?
|
| Diffusion Tensor Imaging | 3 | 2019 | 303 | 0.100 |
Why?
|
| Cognition Disorders | 1 | 2018 | 786 | 0.100 |
Why?
|
| Dietary Supplements | 2 | 2015 | 558 | 0.100 |
Why?
|
| Sweetening Agents | 1 | 2011 | 33 | 0.100 |
Why?
|
| Nerve Tissue Proteins | 1 | 2019 | 1491 | 0.100 |
Why?
|
| Food Industry | 1 | 2011 | 4 | 0.100 |
Why?
|
| Dietary Sucrose | 1 | 2011 | 42 | 0.100 |
Why?
|
| Trans Fatty Acids | 1 | 2011 | 10 | 0.100 |
Why?
|
| Calcium | 3 | 2009 | 1537 | 0.100 |
Why?
|
| Ion Channels | 1 | 2012 | 212 | 0.100 |
Why?
|
| Rats | 7 | 2018 | 6086 | 0.100 |
Why?
|
| Disease Models, Animal | 4 | 2018 | 7222 | 0.100 |
Why?
|
| Hyperlipidemias | 1 | 2013 | 235 | 0.100 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2011 | 93 | 0.100 |
Why?
|
| Endothelium | 1 | 2011 | 158 | 0.100 |
Why?
|
| Fatty Liver | 1 | 2012 | 235 | 0.090 |
Why?
|
| Body Weight | 4 | 2016 | 1293 | 0.090 |
Why?
|
| Cell Differentiation | 1 | 2021 | 4078 | 0.090 |
Why?
|
| Mitochondrial Proteins | 1 | 2012 | 369 | 0.090 |
Why?
|
| Fatty Acids | 1 | 2013 | 448 | 0.090 |
Why?
|
| Depression | 1 | 2020 | 1715 | 0.090 |
Why?
|
| Stroke | 1 | 2017 | 1144 | 0.080 |
Why?
|
| Male | 17 | 2020 | 123000 | 0.080 |
Why?
|
| Ovariectomy | 2 | 2008 | 330 | 0.080 |
Why?
|
| Inflammation | 3 | 2016 | 2522 | 0.080 |
Why?
|
| Receptor, Cannabinoid, CB1 | 1 | 2008 | 33 | 0.080 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenase Type 1 | 1 | 2008 | 3 | 0.080 |
Why?
|
| Aminoimidazole Carboxamide | 1 | 2008 | 34 | 0.080 |
Why?
|
| Ribonucleotides | 1 | 2008 | 52 | 0.080 |
Why?
|
| Lipid Metabolism | 1 | 2011 | 483 | 0.080 |
Why?
|
| Interleukin-8 | 2 | 2008 | 519 | 0.080 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2008 | 184 | 0.080 |
Why?
|
| Oxidative Stress | 2 | 2011 | 1129 | 0.080 |
Why?
|
| Software Design | 1 | 2006 | 40 | 0.070 |
Why?
|
| Diffusion | 1 | 2006 | 88 | 0.070 |
Why?
|
| RNA, Messenger | 5 | 2012 | 6150 | 0.070 |
Why?
|
| Lipoprotein Lipase | 2 | 2003 | 52 | 0.070 |
Why?
|
| Fluorescent Dyes | 2 | 2006 | 459 | 0.070 |
Why?
|
| Proadifen | 1 | 2006 | 1 | 0.070 |
Why?
|
| Tubocurarine | 1 | 2006 | 2 | 0.070 |
Why?
|
| Conotoxins | 1 | 2006 | 2 | 0.070 |
Why?
|
| Dansyl Compounds | 1 | 2006 | 7 | 0.070 |
Why?
|
| Phencyclidine | 1 | 2006 | 7 | 0.070 |
Why?
|
| Behavior, Animal | 2 | 2020 | 709 | 0.070 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2006 | 67 | 0.070 |
Why?
|
| Luminescent Measurements | 1 | 2006 | 148 | 0.070 |
Why?
|
| Calcium Channel Blockers | 1 | 2006 | 135 | 0.070 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2008 | 413 | 0.070 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2008 | 703 | 0.060 |
Why?
|
| Brain | 1 | 2018 | 4113 | 0.060 |
Why?
|
| Lipids | 1 | 2008 | 644 | 0.060 |
Why?
|
| Body Fat Distribution | 2 | 2016 | 29 | 0.060 |
Why?
|
| Cell Separation | 2 | 2021 | 612 | 0.060 |
Why?
|
| Hypoglycemic Agents | 1 | 2008 | 586 | 0.060 |
Why?
|
| Estrogens | 1 | 2008 | 751 | 0.060 |
Why?
|
| Structure-Activity Relationship | 1 | 2006 | 931 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2017 | 7702 | 0.060 |
Why?
|
| Catecholamines | 1 | 2003 | 101 | 0.060 |
Why?
|
| Calcium Channels | 1 | 2004 | 197 | 0.060 |
Why?
|
| Piperidines | 1 | 2008 | 1035 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 3 | 2020 | 6942 | 0.050 |
Why?
|
| Amino Acid Sequence | 2 | 2009 | 4233 | 0.050 |
Why?
|
| Dexamethasone | 2 | 2003 | 1450 | 0.050 |
Why?
|
| Growth Hormone | 1 | 2002 | 226 | 0.050 |
Why?
|
| Case-Control Studies | 3 | 2018 | 6100 | 0.050 |
Why?
|
| Adipogenesis | 1 | 2021 | 105 | 0.050 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 2 | 2011 | 26 | 0.050 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 2 | 2011 | 77 | 0.050 |
Why?
|
| Sex Factors | 2 | 2016 | 2139 | 0.040 |
Why?
|
| Pyrazoles | 1 | 2008 | 1471 | 0.040 |
Why?
|
| Flow Cytometry | 2 | 2021 | 3033 | 0.040 |
Why?
|
| Estradiol | 1 | 2003 | 748 | 0.040 |
Why?
|
| Maternal Behavior | 1 | 2019 | 62 | 0.040 |
Why?
|
| Middle Aged | 6 | 2017 | 86204 | 0.040 |
Why?
|
| Calorimetry, Indirect | 1 | 2018 | 60 | 0.040 |
Why?
|
| Glucose Clamp Technique | 1 | 2018 | 89 | 0.040 |
Why?
|
| Humans | 15 | 2021 | 261506 | 0.040 |
Why?
|
| Enzyme Inhibitors | 1 | 2006 | 1879 | 0.040 |
Why?
|
| Rats, Inbred F344 | 1 | 2018 | 224 | 0.040 |
Why?
|
| Capsaicin | 1 | 2017 | 47 | 0.040 |
Why?
|
| Adiponectin | 2 | 2008 | 163 | 0.040 |
Why?
|
| Mice | 4 | 2020 | 34495 | 0.040 |
Why?
|
| Female | 12 | 2020 | 141928 | 0.040 |
Why?
|
| Microfilament Proteins | 1 | 2019 | 487 | 0.040 |
Why?
|
| Osmosis | 1 | 2016 | 18 | 0.030 |
Why?
|
| Epididymis | 1 | 2016 | 68 | 0.030 |
Why?
|
| Neuroprotective Agents | 1 | 2017 | 215 | 0.030 |
Why?
|
| Down-Regulation | 2 | 2013 | 2074 | 0.030 |
Why?
|
| Glucose Tolerance Test | 1 | 2016 | 213 | 0.030 |
Why?
|
| Fatty Acids, Nonesterified | 2 | 2008 | 159 | 0.030 |
Why?
|
| Macrophages | 1 | 2021 | 1304 | 0.030 |
Why?
|
| Pregnancy | 2 | 2019 | 7573 | 0.030 |
Why?
|
| Up-Regulation | 2 | 2012 | 2450 | 0.030 |
Why?
|
| Protein Conformation | 2 | 2009 | 1258 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2018 | 1338 | 0.030 |
Why?
|
| Cytokines | 1 | 2003 | 2809 | 0.030 |
Why?
|
| Leukocytes | 1 | 2016 | 422 | 0.030 |
Why?
|
| Incretins | 1 | 2013 | 25 | 0.030 |
Why?
|
| Molecular Conformation | 1 | 2013 | 171 | 0.030 |
Why?
|
| Models, Animal | 1 | 2016 | 664 | 0.030 |
Why?
|
| Aging | 1 | 2002 | 1582 | 0.030 |
Why?
|
| Uncoupling Protein 2 | 1 | 2012 | 26 | 0.030 |
Why?
|
| Ghrelin | 1 | 2013 | 79 | 0.030 |
Why?
|
| RNA, Ribosomal, 18S | 1 | 2012 | 25 | 0.030 |
Why?
|
| Molecular Docking Simulation | 1 | 2013 | 144 | 0.030 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2013 | 131 | 0.030 |
Why?
|
| Young Adult | 3 | 2018 | 21445 | 0.030 |
Why?
|
| Cattle | 2 | 2004 | 783 | 0.030 |
Why?
|
| Aspartame | 1 | 2011 | 1 | 0.030 |
Why?
|
| Risk Factors | 3 | 2015 | 17523 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2008 | 8873 | 0.030 |
Why?
|
| Signal Transduction | 3 | 2018 | 11965 | 0.030 |
Why?
|
| Hydrogenation | 1 | 2011 | 3 | 0.030 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2011 | 34 | 0.030 |
Why?
|
| Time | 1 | 2011 | 178 | 0.030 |
Why?
|
| Beverages | 1 | 2011 | 105 | 0.020 |
Why?
|
| Dietary Fats | 1 | 2013 | 339 | 0.020 |
Why?
|
| Soybean Oil | 1 | 2011 | 66 | 0.020 |
Why?
|
| Milk | 1 | 2011 | 120 | 0.020 |
Why?
|
| Diet, High-Fat | 1 | 2012 | 241 | 0.020 |
Why?
|
| Homeostasis | 1 | 2016 | 950 | 0.020 |
Why?
|
| Gene Expression | 2 | 2013 | 3570 | 0.020 |
Why?
|
| Adult | 5 | 2018 | 77950 | 0.020 |
Why?
|
| Biomarkers | 2 | 2012 | 5047 | 0.020 |
Why?
|
| Cell Line | 2 | 2008 | 5114 | 0.020 |
Why?
|
| Metabolic Diseases | 1 | 2011 | 130 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2020 | 5710 | 0.020 |
Why?
|
| Amino Acids | 1 | 2013 | 728 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 2009 | 6089 | 0.020 |
Why?
|
| Postmenopause | 1 | 2011 | 378 | 0.020 |
Why?
|
| Energy Intake | 1 | 2011 | 515 | 0.020 |
Why?
|
| Enzyme Activators | 1 | 2008 | 20 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2009 | 392 | 0.020 |
Why?
|
| Glycerol | 1 | 2008 | 99 | 0.020 |
Why?
|
| Cardiovascular Diseases | 2 | 2011 | 2195 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2009 | 611 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2008 | 4938 | 0.020 |
Why?
|
| Overweight | 1 | 2011 | 484 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2009 | 627 | 0.020 |
Why?
|
| Mammals | 1 | 2009 | 361 | 0.020 |
Why?
|
| Lipectomy | 1 | 2008 | 63 | 0.020 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2012 | 421 | 0.020 |
Why?
|
| Interleukin-1beta | 1 | 2008 | 300 | 0.020 |
Why?
|
| Time Factors | 2 | 2011 | 12926 | 0.020 |
Why?
|
| Ligands | 1 | 2008 | 995 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2008 | 1618 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 3639 | 0.020 |
Why?
|
| Age Factors | 1 | 2014 | 5377 | 0.020 |
Why?
|
| Aminoquinolines | 1 | 2004 | 46 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2008 | 1643 | 0.020 |
Why?
|
| Tryptophan | 1 | 2004 | 127 | 0.020 |
Why?
|
| Isoleucine | 1 | 2003 | 29 | 0.010 |
Why?
|
| Mutation | 2 | 2019 | 15179 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 5159 | 0.010 |
Why?
|
| Protein Subunits | 1 | 2004 | 274 | 0.010 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2003 | 212 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2003 | 568 | 0.010 |
Why?
|
| Alanine | 1 | 2003 | 240 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2004 | 844 | 0.010 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2003 | 105 | 0.010 |
Why?
|
| Depression, Chemical | 1 | 2002 | 52 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 2008 | 992 | 0.010 |
Why?
|
| Glutamine | 1 | 2003 | 299 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 2003 | 461 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2003 | 1487 | 0.010 |
Why?
|
| Weight Gain | 1 | 2002 | 464 | 0.010 |
Why?
|
| Aged | 2 | 2014 | 70117 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2003 | 1538 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 29902 | 0.010 |
Why?
|
| Diet | 1 | 2002 | 1440 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2008 | 14551 | 0.010 |
Why?
|
| Adolescent | 1 | 2013 | 31252 | 0.010 |
Why?
|